A vs IBO · P/E 29, rev $1.88B vs rev $18.0K
Agilent Technologies Inc (A) versus Impact BioMedical, Inc. (IBO) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
A currently screens at market cap $33.70B and trailing P/E 29.2. IBO currently screens at market cap $7.6M.
Not investment advice. Open the A and IBO stock pages for the full models.
Not investment advice.